Researcher looking at developing new therapies

---

Career summary: Since graduating with a PhD in Physiology (1991), I have worked to translate knowledge from fundamental science projects to provide clinical applications. Initially my research interests were centered on the physiology of control of movement, age related neurodegeneration and regeneration.  I have subsequently used this basic science knowledge and applied it into developing novel therapeutic avenues for the treatment of Parkinson’s disease, MSA and parkinsonism.

Community engagement and participation: I am a current board member (2014-) of Parkinson’s Victoria, an organization that raises awareness and funds for services and research that improves the quality of life for people living with MSA and Parkinson’s in Victoria, Australia (http://www.parkinsonsvic.org.au/ ).

 

Involvement with Biotechnology: Based on my knowledge and expertise, I was invited to be scientific consultant for two local biotech companies, Prana Biotechnology Ltd (2006-ongoing) and Procypria Biotechnology Ltd (2009-2012), as well as international companies, Commonwealth Serum laboratories (2009-2012) and the Collaborative Medicinal Development LLC, USA (2013-present). The aim of consulting with these companies is to work in partnership to develop new compounds that could potentially slow the progression of neurodegenerative diseases. My skills lie in the pre-clinical testing of new compounds in animal models of disease.